MX2016010918A - Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos. - Google Patents

Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos.

Info

Publication number
MX2016010918A
MX2016010918A MX2016010918A MX2016010918A MX2016010918A MX 2016010918 A MX2016010918 A MX 2016010918A MX 2016010918 A MX2016010918 A MX 2016010918A MX 2016010918 A MX2016010918 A MX 2016010918A MX 2016010918 A MX2016010918 A MX 2016010918A
Authority
MX
Mexico
Prior art keywords
magnesium oxide
applications
food additive
oxide granules
pharmaceutical
Prior art date
Application number
MX2016010918A
Other languages
English (en)
Other versions
MX368918B (es
Inventor
Sakamoto Kensho
Original Assignee
Konoshima Chemical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54008312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016010918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Konoshima Chemical filed Critical Konoshima Chemical
Publication of MX2016010918A publication Critical patent/MX2016010918A/es
Publication of MX368918B publication Critical patent/MX368918B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/22—Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F5/00—Compounds of magnesium
    • C01F5/02—Magnesia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Geology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Un objetivo de la presente invención es el proveer óxido de magnesio que puede ser usado preferiblemente para aplicaciones farmacéuticas o como un aditivo para alimentos. En particular, el objetivo es proveer gránulos de óxido de magnesio con los cuales se pueden reducir los problemas en el pastillado, así como también se pueden reducir los defectos de calidad, y más particularmente, proveer gránulos de óxido de magnesio con los cuales los problemas de fabricación de tabletas y los defectos de calidad pueden ser reducidos y los cuales tienen una menor incorporación de metales pesados y una alta pureza del óxido de magnesio. Se proveen gránulos de óxido de magnesio para aplicaciones farmacéuticas o para la adición a alimentos que tienen un área de superficie específica BET de 7 a 50 m2/g y CAA80/CAA40 de 2 a 7.
MX2016010918A 2014-02-25 2014-02-25 Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos. MX368918B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2014/054516 WO2015128940A1 (ja) 2014-02-25 2014-02-25 医薬用又は食品添加用酸化マグネシウム顆粒

Publications (2)

Publication Number Publication Date
MX2016010918A true MX2016010918A (es) 2016-11-14
MX368918B MX368918B (es) 2019-10-21

Family

ID=54008312

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010918A MX368918B (es) 2014-02-25 2014-02-25 Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos.

Country Status (7)

Country Link
US (1) US10004763B2 (es)
EP (1) EP3111957B1 (es)
JP (1) JP6343338B2 (es)
CN (1) CN106029103B (es)
CA (1) CA2938003C (es)
MX (1) MX368918B (es)
WO (1) WO2015128940A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018030225A1 (ja) * 2016-08-09 2018-02-15 神島化学工業株式会社 酸化マグネシウム顆粒
CN107927883A (zh) * 2018-01-05 2018-04-20 长沙兴嘉生物工程股份有限公司 一种微量营养素补充剂颗粒的制备方法及制备装置
FR3092993B1 (fr) * 2019-02-21 2021-05-21 Timab Magnesium Supplément à base de magnésium pour volailles
US11865139B2 (en) * 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
CN116143150A (zh) * 2021-09-01 2023-05-23 河北镁神科技有限公司 一种压片用食品级颗粒氧化镁及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443425A (en) * 1981-12-09 1984-04-17 Calgon Corporation Magnesium oxide composition for coating silicon steel
JP2665451B2 (ja) 1993-12-28 1997-10-22 タテホ化学工業株式会社 アルカリ土類金属酸化物の製造方法
JP4192282B2 (ja) 1997-12-01 2008-12-10 Ｊｆｅスチール株式会社 焼鈍分離剤用ＭｇＯの製造方法
JP4192283B2 (ja) 1997-12-24 2008-12-10 Ｊｆｅスチール株式会社 方向性電磁鋼板の製造方法
JP2001048792A (ja) 1998-11-26 2001-02-20 Fujix Kk 瀉下剤
JP3939102B2 (ja) 2001-03-05 2007-07-04 宇部マテリアルズ株式会社 低Ｐｂ酸化マグネシウムからなる食品添加剤
JP2003033159A (ja) * 2001-07-24 2003-02-04 Kyowa Hakko Kogyo Co Ltd 食品添加用酸化マグネシウム粉末
KR20090065552A (ko) 2001-08-27 2009-06-22 교와 가가꾸고교 가부시키가이샤 제산 ·완하용 정제
JP4015485B2 (ja) 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
JP4833567B2 (ja) 2005-03-14 2011-12-07 協和発酵バイオ株式会社 酸化マグネシウム粒子
JP5160156B2 (ja) 2007-07-05 2013-03-13 株式会社オオツカ 栄養機能食品錠剤
JP4714929B2 (ja) * 2008-02-29 2011-07-06 富田製薬株式会社 酸に不安定な薬剤用安定化剤
JP5564040B2 (ja) * 2009-04-22 2014-07-30 協和化学工業株式会社 錠剤
RU2501561C1 (ru) 2009-09-08 2013-12-20 Киова Кемикал Индастри Ко., Лтд. Антацидная и слабительная таблетка
JP5415215B2 (ja) 2009-10-02 2014-02-12 タテホ化学工業株式会社 分散性に優れる酸化マグネシウム粉末及びその製造方法
CN102515576B (zh) * 2011-12-05 2016-03-30 韩大庆 磷酸镁水泥用氧化镁及其制备方法和磷酸镁水泥

Also Published As

Publication number Publication date
EP3111957B1 (en) 2018-11-21
JPWO2015128940A1 (ja) 2017-03-30
JP6343338B2 (ja) 2018-06-13
MX368918B (es) 2019-10-21
CN106029103B (zh) 2021-12-31
CA2938003C (en) 2019-01-08
EP3111957A4 (en) 2017-10-25
US20170042935A1 (en) 2017-02-16
CN106029103A (zh) 2016-10-12
US10004763B2 (en) 2018-06-26
WO2015128940A1 (ja) 2015-09-03
CA2938003A1 (en) 2015-09-03
EP3111957A1 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
IL294782B1 (en) Polypeptide substrates that activate matriptase and u-plasminogen and other cleavable groups, preparations containing them and their uses
NZ734233A (en) Pharmaceutical compositions comprising meloxicam
EP3225619A4 (en) 2-aminopyrimidine compound and pharmaceutical composition and use thereof
EP3113800A4 (en) Enhanced production of recombinant crm197 in e. coli
MX368918B (es) Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos.
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
EP3513283A4 (en) PROCESSING OF CONTENT IN APPLICATIONS
EP3233111A4 (en) Pharmaceutical composition comprising plasminogen and uses thereof
WO2015191945A3 (en) Solid state forms of sofosbuvir
EP3133152A4 (en) Novel bacteriophage, and composition containing same
EP3491551A4 (en) GEOMETRY-BASED, SPACE-CONSCIOUS SHELF / WRITEGROUP EVACUATION
EP3123287A4 (en) Alternate dynamic keyboard for convertible tablet computers
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EP3135293A4 (en) Agent for preventing or ameliorating diabetes
EP3297440A4 (en) COMPOSITION WITH CARBOPLATIN AND USE
EP3267987A4 (en) CHEMICALLY MODIFIED CLUROMES FOR USE IN THE PREPARATION OF LIPOXINES
EP3129347A4 (en) Reactions in the presence of ruthenium complexes
EP3331504A4 (en) TABLET COMPOSITION FOR ANTIBIOTICS AGAINST TUBERCULOSIS
PL3645016T3 (pl) Połączenie zawierające tlen i kwas hialuronowy do stosowania miejscowego-dopochwowego
IN2014MU00916A (es)
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
EP3197438A4 (en) Pharmaceutical composition having improved content uniformity
WO2016020408A3 (en) Compounds for preventing ototoxicity
EP3114130A4 (en) Pyridyldiamido transition metal complexes, production and use thereof
AU2018297022A1 (en) Table top

Legal Events

Date Code Title Description
FG Grant or registration